Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
BLOG
EVENT CALENDAR
COLUMNS
WHITE PAPERS
THE MAGAZINE
  Pharmaceutical Technology Europe E-Alert
 
9 November 2012

IN THIS ISSUE
• False claims allegations
• Gene therapy
• New Novartis plant
• Watson & Actavis
• USP revisions

Boehringer Ingelheim Settles False Claims Allegations
Boehringer Ingelheim has agreed to pay $95 million to settle allegations that it improperly promoted the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease drugs Atrovent and Combivent, and the hypertension drug Micardis. More...
 
EC Approves Europe's First Gene Therapy
The European Commission (EC) has issued final approval for Europe’s first gene therapy —a treatment for a rare genetic disorder that currently has no other treatment options. More...
 
Novartis invests US$500 million in new biologics facility in Singapore
Novartis is investing more than half a billion US dollars in the construction of a new state-of-the-art biotechnology production site in Singapore for the manufacture of drugs based on cell culture technology. More...
 
Watson Completes Acquisition of Actavis
Watson Pharmaceuticals has completed its EUR 4.25 billion acquisition of the Actavis Group. The combination creates the world’s third largest generic-drug pharmaceutical company, with anticipated pro forma combined 2012 revenues in excess of $8 billion. More...
 
USP Changes Heparin Labeling Requirement
The United States Pharmacopeia Convention (USP) has revised its current labeling standards for heparin sodium injections and heparin lock flush solutions to address safety concerns about the expression of the drugs’ strength. More...
 
Get the Latest Updates on Twitter
We regularly tweet the latest news and rumours hitting the web about the pharmaceutical industry. Follow us to keep up to date. More...
Key Topics:

Latest blog posts
FDA Assesses Goals due to Hurricane Sandy
Pharma's Efforts in Hurricane Sandy
2012 European Outsourcing Award Winners
More blog posts

Latest articles
Combination Drugs: Adding Up the Opportunities
Strategies in Outsourcing Facilities Management
Report from India
More articles

Upcoming events
Asia Pharma R&D Outsourcing Congress (26–27 November | UK)
World Drug Manufacturing Summit (26–28 November | Germany)
Pharma Integrates 2012 (28–29 November | UK)
More events

Products/Service Profiles
Celanese

Learn more about VitalDose® EVA excipients on the VitalDose blog.
Learn how EVA polymers have been used for years in controlled release pharmaceutical and medical device applications. Read more
 
Tosoh

TOYOPEARL® MX-Trp-650M Mixed-Mode Resin
TOYOPEARL MX-Trp-650M is a new multimodal cation exchange resin with unique selectivity and high recovery. It provides high protein binding capacities and tolerates high conductivity feedstocks. Read more

Event profile

11th Annual World Drug Manufacturing Summit
26-28th November 2012
Venue: Swissôtel, Düsseldorf, Germany
The Annual World Drug Manufacturing Summit sources and presents leading global case studies from Pfizer, GSK, AstraZeneca, Baxter, Bayer and many more. Read More

Survey
Concerns have recently been raised about the safety of confidential data at FDA. Do you think regulators are doing enough to protect confidential data?
 
Yes 38%
 
 
No 63%

This week we would like to know...

2012 has been touted as a crucial year of the so-called patent cliff. Do you think the impact of patent expiries has been better or worse than expected?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.